Variant report

Variant	nsv550284
Chromosome Location	chr10:28341783-28400835
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:11)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:1)

No data

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:28372312..28376657-chr10:28391120..28396968,5	K562	blood:
2	chr10:28364402..28367665-chr10:28377622..28380231,3	MCF-7	breast:
3	chr10:28362265..28365237-chr10:28365253..28367161,2	K562	blood:
4	chr10:28387058..28389693-chr6:27776467..27779114,2	MCF-7	breast:
5	chr10:28364402..28367665-chr10:28377622..28380231,3	MCF-7	breast:
6	chr10:28362265..28365237-chr10:28365253..28367161,2	K562	blood:
7	chr10:28397069..28398753-chr10:28400190..28402343,2	K562	blood:
8	chr10:28397069..28398753-chr10:28400190..28402343,2	K562	blood:
9	chr10:28384110..28385653-chr10:28390069..28392151,2	MCF-7	breast:
10	chr10:28372312..28376657-chr10:28391120..28396968,5	K562	blood:
11	chr10:28384110..28385653-chr10:28390069..28392151,2	MCF-7	breast:

No data

(count:1 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	MPP7	hsa-miR-32-5p	chr10:28342051-28342072

Variant related genes	Relation type
ENSG00000203813	chromatin interactions

Extended variants
information (count: 2152 )
Associated
traits (count: 45 )

Variant overlapped rSNPs/rCNVs (count:2152 , 50 per page) page: 1 2 3 4 5 6 7 ... 44

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs3802520	chr10:28341783-28341784	Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs183132391	chr10:28341803-28341804	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs3802521	chr10:28341812-28341813	Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs528640027	chr10:28341825-28341826	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs535982568	chr10:28341837-28341838	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs3802522	chr10:28341866-28341867	Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
7	rs3802523	chr10:28341885-28341886	Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs550877200	chr10:28341904-28341905	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs41283716	chr10:28342021-28342022	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs11006814	chr10:28342053-28342054	Weak transcription Strong transcription	miRNA target site	1 gene(s)	Overlapped CNVs	n/a
11	rs190331996	chr10:28342137-28342138	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs570071754	chr10:28342237-28342238	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs36075634	chr10:28342293-28342294	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs78585958	chr10:28342294-28342295	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs183004997	chr10:28342366-28342367	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs568177474	chr10:28342396-28342397	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs188259972	chr10:28342513-28342514	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs556857474	chr10:28342527-28342528	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs575657505	chr10:28342602-28342603	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs41299220	chr10:28342633-28342634	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs112476468	chr10:28342650-28342651	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs558194843	chr10:28342679-28342680	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs573230476	chr10:28342734-28342735	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs12249305	chr10:28342740-28342741	Enhancers Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs192494131	chr10:28342793-28342794	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs529344844	chr10:28342806-28342807	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs78112140	chr10:28342820-28342821	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs117818385	chr10:28342829-28342830	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs533453423	chr10:28342887-28342888	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs184421869	chr10:28342897-28342898	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs111395739	chr10:28342909-28342910	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs76615154	chr10:28342916-28342917	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs546262734	chr10:28342927-28342928	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs369028546	chr10:28342956-28342957	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs372516984	chr10:28342957-28342958	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs201556820	chr10:28342984-28342985	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs200132907	chr10:28343006-28343007	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs143372624	chr10:28343024-28343025	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs375543808	chr10:28343031-28343032	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs199872182	chr10:28343059-28343060	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs369775608	chr10:28343061-28343062	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs147221652	chr10:28343067-28343068	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs17853796	chr10:28343069-28343070	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs35462650	chr10:28343132-28343133	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs201992277	chr10:28343142-28343143	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs534236071	chr10:28343198-28343199	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs555470202	chr10:28343238-28343239	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs148662103	chr10:28343279-28343280	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs574126805	chr10:28343370-28343371	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs114939533	chr10:28343405-28343406	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:45)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
T-cell lymphomas	19863542	CNVD
Esophageal cancer	21851588	CNVD
Behavioral abnormalities	21522184	CNVD
Dysmorphic features	21522184	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	21364760	CNVD
abnormal development	18461090	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	22048815	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	22341455	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:688 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:28330000-28345000	Weak transcription	Pancreas	Pancrea
2	chr10:28331200-28345000	Weak transcription	Aorta	Aorta
3	chr10:28334800-28341800	Weak transcription	Primary monocytes fromperipheralblood	blood
4	chr10:28335000-28345800	Weak transcription	Brain Angular Gyrus	brain
5	chr10:28335600-28345000	Weak transcription	Fetal Stomach	stomach
6	chr10:28336200-28349400	Weak transcription	Gastric	stomach
7	chr10:28336400-28346000	Weak transcription	Pancreatic Islets	Pancreatic Islet
8	chr10:28336600-28345600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
9	chr10:28336800-28346600	Weak transcription	Primary hematopoietic stem cells	blood
10	chr10:28337400-28341800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
11	chr10:28337400-28342600	Weak transcription	Primary T helper cells fromperipheralblood	blood
12	chr10:28337400-28347400	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
13	chr10:28337600-28342400	Weak transcription	Primary T helper cells PMA-I stimulated	--
14	chr10:28337800-28345000	Weak transcription	Fetal Intestine Small	intestine
15	chr10:28337800-28346000	Weak transcription	Skeletal Muscle Male	skeletal muscle
16	chr10:28338200-28345000	Weak transcription	Left Ventricle	heart
17	chr10:28338400-28345000	Weak transcription	Esophagus	oesophagus
18	chr10:28338600-28342600	Weak transcription	NHDF-Ad	bronchial
19	chr10:28338800-28341800	Weak transcription	Primary neutrophils fromperipheralblood	blood
20	chr10:28338800-28342400	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
21	chr10:28339000-28345000	Weak transcription	Lung	lung
22	chr10:28339800-28342400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
23	chr10:28339800-28345000	Weak transcription	Primary T cells from cord blood	blood
24	chr10:28340200-28342400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
25	chr10:28340800-28342400	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
26	chr10:28341200-28350000	Strong transcription	Monocytes-CD14+_RO01746	blood
27	chr10:28341200-28377600	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
28	chr10:28341400-28346400	Weak transcription	Spleen	Spleen
29	chr10:28341600-28342600	Weak transcription	Rectal Smooth Muscle	rectum
30	chr10:28341800-28348600	Strong transcription	Primary mononuclear cells fromperipheralblood	Blood
31	chr10:28341800-28349000	Strong transcription	Primary neutrophils fromperipheralblood	blood
32	chr10:28341800-28349800	Strong transcription	Primary monocytes fromperipheralblood	blood
33	chr10:28342200-28345000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
34	chr10:28342400-28342600	Enhancers	Stomach Smooth Muscle	stomach
35	chr10:28342400-28342600	Weak transcription	HSMMtube	muscle
36	chr10:28342400-28342800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
37	chr10:28342400-28343000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
38	chr10:28342400-28343000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
39	chr10:28342400-28343200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
40	chr10:28342400-28343400	Strong transcription	Primary T helper cells PMA-I stimulated	--
41	chr10:28342400-28344000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
42	chr10:28342400-28344200	Strong transcription	Primary Natural Killer cells fromperipheralblood	blood
43	chr10:28342400-28344600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
44	chr10:28342400-28344600	Enhancers	Muscle Satellite Cultured Cells	--
45	chr10:28342400-28345000	Enhancers	Hela-S3	cervix
46	chr10:28342400-28348400	Strong transcription	Primary T helper naive cells fromperipheralblood	blood
47	chr10:28342600-28342800	Enhancers	HMEC	breast
48	chr10:28342600-28342800	Enhancers	HSMMtube	muscle
49	chr10:28342600-28343200	Enhancers	NHLF	lung
50	chr10:28342600-28343400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links